GlassScriptPhysician profile
Shawn Dhillon
NPI 1215914437
$226,832.91
in general payments reported to CMS, 2019-2025
69 companies · $48K in 2025
The $48K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $13K · 2021: $6,746 · 2022: $17K · 2023: $26K · 2024: $50K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $67K · Food and Beverage: $23K · Travel and Lodging: $17K · Consulting Fee: $14K · Honoraria: $3,000 · Education: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $66,892.00 |
| Food and Beverage | $22,628.83 |
| Travel and Lodging | $17,285.41 |
| Consulting Fee | $13,774.00 |
| Honoraria | $3,000.00 |
| Education | $187.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $65,830.77 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $58,256.39 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $49,524.00 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Kowa Pharmaceuticals America, INC. | $9,366.02 | 2019-2025 | Seglentis, Livalo, Zoryve |
| Allergan, INC. | $7,033.46 | 2019-2022 | |
| Pfizer INC. | $6,588.39 | 2019-2025 | |
| Abbvie INC. | $5,128.28 | 2021-2025 | Qulipta, Ubrelvy, Linzess |
| Amgen INC. | $3,815.30 | 2019-2025 | Krystexxa, Repatha |
| Horizon Therapeutics Plc | $3,346.69 | 2019-2023 | Krystexxa |
| Viiv Healthcare Company | $2,536.01 | 2019-2025 | Dovato, Cabenuva, Apretude |
| Novo Nordisk INC | $2,057.54 | 2019-2025 | Rybelsus, Ozempic |
| Mallinckrodt Hospital Products INC. | $1,282.70 | 2021-2025 | Acthar |
| Dexcom, INC. | $974.72 | 2020-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Akebia Therapeutics INC | $970.07 | 2019-2025 | Auryxia, Vafseo |
| Novartis Pharmaceuticals Corporation | $956.62 | 2019-2025 |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $751.06 | 2019-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $647.96 | 2019-2023 | Xarelto |
| Gilead Sciences, INC. | $587.08 | 2019-2025 | |
| Ani Pharmaceuticals, INC. | $484.54 | 2022-2025 | Purified Cortrophin Gel |
| Sanofi-Aventis U.S. LLC | $444.97 | 2021-2022 | |
| Esperion Therapeutics, INC. | $364.37 | 2020-2024 | Nexletol |
| Travere Therapeutics, INC. | $356.43 | 2019-2025 | Filspari |
| Otsuka America Pharmaceutical, INC. | $351.48 | 2019-2025 | Jynarque, Voyxact |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.72 | 2020-2024 | Ofev, Jardiance |
| E.R. Squibb & Sons, L.L.C. | $321.45 | 2019-2025 | Camzyos |
| Glaxosmithkline, LLC. | $317.41 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $288.25 | 2023-2025 | Gemtesa |
| Vifor Pharma, INC. | $254.90 | 2019-2023 | Veltassa, Korsuva |
| Cequr Corporation | $244.56 | 2023-2024 | Cequr Simplicity |
| Protega Pharmaceutials INC | $234.69 | 2023-2024 | Roxybond |
| Merck Sharp & Dohme LLC | $230.62 | 2019-2025 | Pifeltro, Capvaxive |
| Fresenius USA Marketing, INC. | $225.09 | 2019-2025 | Velphoro, Velphoro |
| Lilly USA, LLC | $223.14 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $220.69 | 2022-2024 | Caplyta |
| Calliditas Therapeutics US INC. | $173.31 | 2022-2025 | Tarpeyo |
| Idorsia Pharmaceuticals US INC | $164.27 | 2023-2024 | Quviviq |
| Exact Sciences Corporation | $155.39 | 2025 | Cologuard Collection Kit |
| Globus Medical, INC. | $124.17 | 2023 | Excelsiusgps Robotic Navigation System |
| Beta Bionics, INC. | $113.79 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Urovant Sciences INC | $113.64 | 2022 | |
| Phadia US INC. | $107.44 | 2023-2024 | Immunocap |
| Sunovion Pharmaceuticals INC. | $102.76 | 2022 | |
| Corcept Therapeutics | $100.38 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $74.43 | 2020-2024 | |
| Mylan Specialty L.P. | $73.58 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $70.80 | 2023-2024 | Inpefa |
| Tactile Systems Technology INC | $70.21 | 2025 | Nimbl, Flexitouch Plus |
| Cashflow Solutions, LLC | $67.89 | 2023 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Eisai INC. | $67.62 | 2020-2021 | |
| Abbott Laboratories | $62.23 | 2024-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $61.99 | 2022 | |
| Verona Pharma, INC. | $61.17 | 2025 | Ohtuvayre |
| Ultragenyx Pharmaceutical INC. | $56.15 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $55.85 | 2023 | Ryaltris, Kloxxado |
| Daiichi Sankyo INC. | $53.69 | 2022 | |
| Alexion Pharmaceuticals, INC. | $46.74 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $46.24 | 2024 | Nuzyra |
| Sanofi Pasteur INC. | $43.32 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $39.80 | 2025 | Belbuca |
| Alk-Abello, INC | $30.35 | 2019-2020 | |
| Valeritas, INC. | $22.15 | 2019 | |
| Scpharmaceuticals INC. | $21.38 | 2025 | |
| Impel Pharmaceuticals INC. | $18.07 | 2022 | |
| Opko Pharmaceuticals, LLC | $16.85 | 2022 | |
| Orexo US, INC. | $16.61 | 2021 | |
| Zealand Pharma US, INC. | $15.50 | 2020 | |
| Tms Neurohealth Centers INC. | $15.31 | 2025 | Tms Neurohealth Centers INC. |
| Ardelyx, INC. | $13.54 | 2023 | Ibsrela |
| Arbor Pharmaceuticals, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Dhillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.